Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Javier Cubero

Showing results (11-20 of 134) with videos related to

Pageof 14
Sort By:
Frontiers in Cell and Developmental Biology|December 20, 2023
Obesity under the moonlight of c-MYCYulia A Nevzorova, Francisco Javier Cubero
Frontiers in Pharmacology|November 28, 2022
Editorial: Advances in non-alcoholic fatty liver disease therapeutics: Pathogenic mechanisms and targetsAna Blas-García, Francisco Javier Cubero
Nutritional Neuroscience|November 22, 2016
Diet and nutrients in the modulation of infant sleep: A review of the literatureNora Schneider, Gisella Mutungi, Javier Cubero
Med (New York, N.Y.)|May 11, 2024
Seladelpar: New hope for patients with primary biliary cholangitisYulia A Nevzorova, Francisco Javier Cubero
Hepatology (Baltimore, Md.)|June 1, 2010
c-Jun NH(2)-terminal kinase 1 in hepatocytes: an essential mediator of insulin resistanceFrancisco Javier Cubero, Oliver Drvarov, Christian Trautwein
Gut|October 28, 2023
Advancing with cancer immunotherapeutics: CD29<sup>+</sup> regulatory T cell antagonismFrancisco Javier Cubero, Pablo Sarobe, Gisa Tiegs
Gut|May 4, 2026
Tumour-autonomous IL-6 signalling creates a metabolic vulnerability in intrahepatic cholangiocarcinomaFrancisco Javier Cubero, Rocio I R Macias
Gut|March 20, 2019
Plasticity of adult hepatocytes and readjustment of cell fate: a novel dogma in liver diseaseFrancisco Javier Cubero, Maria Luz Martinez-Chantar
Seminars in Liver Disease|April 24, 2009
Alcohol and liver fibrosisFrancisco Javier Cubero, Raquel Urtasun, Natalia Nieto
Hepatology (Baltimore, Md.)|August 29, 2009
TAL deficiency, all roads lead to oxidative stress?Maximilian Hatting, Christian Trautwein, Francisco Javier Cubero
Pageof 14

Showing results (11-20 of 134) with videos related to

Sort By:
Pageof 14
Frontiers in Cell and Developmental Biology|December 20, 2023
Obesity under the moonlight of c-MYCYulia A Nevzorova, Francisco Javier Cubero
Frontiers in Pharmacology|November 28, 2022
Editorial: Advances in non-alcoholic fatty liver disease therapeutics: Pathogenic mechanisms and targetsAna Blas-García, Francisco Javier Cubero
Nutritional Neuroscience|November 22, 2016
Diet and nutrients in the modulation of infant sleep: A review of the literatureNora Schneider, Gisella Mutungi, Javier Cubero
Med (New York, N.Y.)|May 11, 2024
Seladelpar: New hope for patients with primary biliary cholangitisYulia A Nevzorova, Francisco Javier Cubero
Hepatology (Baltimore, Md.)|June 1, 2010
c-Jun NH(2)-terminal kinase 1 in hepatocytes: an essential mediator of insulin resistanceFrancisco Javier Cubero, Oliver Drvarov, Christian Trautwein
Gut|October 28, 2023
Advancing with cancer immunotherapeutics: CD29<sup>+</sup> regulatory T cell antagonismFrancisco Javier Cubero, Pablo Sarobe, Gisa Tiegs
Gut|May 4, 2026
Tumour-autonomous IL-6 signalling creates a metabolic vulnerability in intrahepatic cholangiocarcinomaFrancisco Javier Cubero, Rocio I R Macias
Gut|March 20, 2019
Plasticity of adult hepatocytes and readjustment of cell fate: a novel dogma in liver diseaseFrancisco Javier Cubero, Maria Luz Martinez-Chantar
Seminars in Liver Disease|April 24, 2009
Alcohol and liver fibrosisFrancisco Javier Cubero, Raquel Urtasun, Natalia Nieto
Hepatology (Baltimore, Md.)|August 29, 2009
TAL deficiency, all roads lead to oxidative stress?Maximilian Hatting, Christian Trautwein, Francisco Javier Cubero
Pageof 14